SEC Form 4 · accession 0001127602-16-052306
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Zaccardelli
Officer — EVP & Chief Operating Officer
Period of report
May 13, 2016
Accepted (ET)
May 16, 2016 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 13, 2016 | M | 10,750 | $47.50 | A | 12,292 | D | |
| Common Stock | May 13, 2016 | M | 11,500 | $61.06 | A | 23,792 | D | |
| Common Stock | May 13, 2016 | M | 64,000 | $65.80 | A | 87,792 | D | |
| Common Stock | May 13, 2016 | M | 25,000 | $94.96 | A | 112,792 | D | |
| Common Stock | May 13, 2016 | D | 10,750 | $111.48 | D | 102,042 | D | |
| Common Stock | May 13, 2016 | D | 11,500 | $111.48 | D | 90,542 | D | |
| Common Stock | May 13, 2016 | D | 64,000 | $111.48 | D | 26,542 | D | |
| Common Stock | May 13, 2016 | D | 25,000 | $111.48 | D | 1,542 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Tracking Award | $47.50 | May 13, 2016 | M | 10,750 | D | Mar 15, 2013 | Mar 15, 2022 | Common Stock | 10,750 | 0 | D |
| Share Tracking Award | $61.06 | May 13, 2016 | M | 11,500 | D | Mar 15, 2014 | Mar 15, 2023 | Common Stock | 11,500 | 11,500 | D |
| Share Tracking Award | $65.80 | May 13, 2016 | M | 64,000 | D | Mar 15, 2012 | Mar 15, 2021 | Common Stock | 64,000 | 0 | D |
| Share Tracking Award | $94.96 | May 13, 2016 | M | 25,000 | D | Mar 14, 2015 | Mar 14, 2024 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.